Plasma constituents and mortality in rat pups given chronic insulin via injection, pellet, or osmotic minipump

Carl I. Thompson, John W. Munford, Edward H. Buell, Robert J. Karry, Charles T. Lee, Benjamin L. Morgan, Alexander J. Radnovich

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Two studies compared the glucose responses of 9-day-old rats given subcutaneous insulin, either continuously or via daily injection, for 10 days. In Experiment 1, implanted pellets released a total of 0, 1.9, or 5.7 U insulin/kg the first 24 h. Injected doses were larger, 0 or 8 U/kg. Injections caused no deaths, but insulin-releasing pellets caused high mortality within 24 h. Pups surviving the pellets were normoglycemic by treatment day 8. In Experiment 2, pups received 0.184 U of insulin daily, approximately 8 U/kg at 9 days, via either injection or osmotic minipump. All pups survived. Injected pups were hypoglycemic 2 h postinjection through treatment day 10, whereas pups with insulin minipumps were normoglycemic by day 5. Insulin injections, but not minipumps, lowered plasma triglycerides on day 10. To examine age differences in response to insulin, additional pups and adults received daily injections of 0 or 8 U/kg for 10 days. All survived. Insulin lowered plasma glucose more in pups than in adults and reduced triglycerides in pups but not in adults. The rapid development of normoglycemia in pups with insulin minipumps, compared with pups injected daily with the same dose, suggests that continuous early insulin may produce insulin resistance.

Original languageEnglish (US)
Pages (from-to)180-192
Number of pages13
JournalCanadian Journal of Physiology and Pharmacology
Issue number3
StatePublished - 2002


  • Development
  • Insulin resistance
  • Mortality
  • Plasma glucose
  • Route of insulin administration

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Fingerprint Dive into the research topics of 'Plasma constituents and mortality in rat pups given chronic insulin via injection, pellet, or osmotic minipump'. Together they form a unique fingerprint.

Cite this